Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daniel Sur"'
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 17, p 5036 (2022)
Pain is a highly debilitating emotional and sensory experience that significantly affects quality of life (QoL). Numerous chronic conditions, including cancer, are associated with chronic pain. In the setting of malignancy, pain can be a consequence
Externí odkaz:
https://doaj.org/article/c5a98bdcd4c94749b2701400a3a0bee5
Autor:
Daniel Sur, Andrei Havasi, Calin Cainap, Gabriel Samasca, Claudia Burz, Ovidiu Balacescu, Iulia Lupan, Diana Deleanu, Alexandru Irimie
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 1, p 182 (2020)
Chimeric antigen receptor (CAR) T-cell therapy represents a new genetically engineered method of immunotherapy for cancer. The patient’s T-cells are modified to express a specific receptor that sticks to the tumor antigen. This modified cell is the
Externí odkaz:
https://doaj.org/article/98f423dc95b74b3980dccbe2b7c355fc
Autor:
Daniel Sur, Andrei Havasi, Gabriel Samasca, Ovidiu Balacescu, AlexandruIrimie, Claudia Burz, Calin Cainap, Diana Deleanu, Iulia Lupan
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 1, p 182 (2020)
Journal of Clinical Medicine, Vol 9, Iss 1, p 182 (2020)
Chimeric antigen receptor (CAR) T-cell therapy represents a new genetically engineered method of immunotherapy for cancer. The patient’s T-cells are modified to express a specific receptor that sticks to the tumor antigen. This modified cell is the
Autor:
Camila Caram-Deelder, Hellen McKinnon Edwards, Jarmila A. Zdanowicz, Thomas van den Akker, Camilla Birkegård, Jan Blatný, Johanna G. van der Bom, Giuseppe Colucci, Derek van Duuren, Nan van Geloven, Dacia D. C. A. Henriquez, Marian Knight, Lars Korsholm, Andrea Landorph, Géraldine Lavigne Lissalde, Zoe K. McQuilten, Daniel Surbek, Cameron Wellard, Erica M. Wood, Frederic J. Mercier
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 9, p 2656 (2024)
Background: Despite a range of available treatments, it is still sometimes challenging to treat patients with severe post-partum hemorrhage (sPPH). Objective: This study evaluated the efficacy and safety of recombinant activated factor VIIa (rFVIIa)
Externí odkaz:
https://doaj.org/article/f2fd79a1064749498cbf2a06d9ac1688
Autor:
Gianluca Guarnieri, Filip David Constantin, Giovanni Pedrazzini, Maria Antonella Ruffino, Daniel Sürder, Roberta Petrino, Enrico Carlo Zucconi, Luca Gabutti, Adam Ogna, Brenno Balestra, Marco Valgimigli
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 9, p 2457 (2024)
The Swiss Ticino regional pulmonary embolism response team (PERT) features direct access to various pharmacomechanical PE management options within a hub/spoke system, by integrating evidence, guidelines’ recommendations and personal experiences. T
Externí odkaz:
https://doaj.org/article/83eb79594eb84b67869aa8a33e589153
Autor:
Jarmila Anna Zdanowicz, Sophie Schneider, Carla Martignoni, Salima Lamari, Alexander Fuchs, Michael Daskalakis, Daniel Surbek
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 23, p 7471 (2023)
Postpartum hemorrhage (PPH) remains a major cause of maternal morbidity and mortality. While PPH treatment guidelines exist, data on their effect on reduction in red blood cell (RBC) transfusions and use of hemostatic products are scarce. Continuous
Externí odkaz:
https://doaj.org/article/f8d09fca33804486a8f5113f3be0338d